The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans and is often treated with a CPAP machine, but is often declined due to its ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

Georgia, Notre Dame fans make Sugar Bowl decision as game is postponed over terror attack A Little Boy Found a Strange Stone ...

The rent-to-own policy, in particular, epitomizes this broken system. It penalizes patients who depend on critical medical ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

What many dismiss as a mere nighttime nuisance often signals deeper health issues requiring medical attention. While snoring ...

A sleep laboratory in Kolkata is campaigning to normalize insurance coverage for Obstructive Sleep Apnea (OSA), a common but ...

Poor sleep hygiene can lead to negative health outcomes, but what exactly is sleep hygiene and how can you improve it?

From sleep apnea notifications to a number of new health and fitness tools, WatchOS 11 adds a lot of new functionality to ...

WAKE-UP CALL: 104m Indians or 11% of the population suffer from obstructive sleep apnea, according to a 2023 AIIMS study ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

The sleep disorders center at Bradford Regional Medical Center achieved a milestone in patient care by completing over 1,000 ...